Abstract The essential role of transferrin in mammalian iron metabolism is firmly established. Integral to our understanding of transferrin, studies in hypotransferrinemic mice, a model of inherited transferrin deficiency, have demonstrated that transferrin is essential for iron delivery for erythropoiesis and in the regulation of expression of hepcidin, a hormone that inhibits macrophage and enterocyte iron efflux. Here we investigate a potential role for transferrin in the distribution of three other physiologic metals, manganese, copper, and zinc. We first assessed metal content in transferrin-rich fractions of wild-type mouse sera and demonstrate that although both iron and manganese cofractionated predominantly with transferrin, the absolute levels of manganese are several orders of magnitude lower than those of iron. We next measured metal content in multiple tissues in wild-type and hypotransferrinemic mice of various ages. Tissue metal imbalances were severe for iron and minimal to moderate for some metals in some tissues in hypotransferrinemic mice. Metal levels measured in a transferrin-replete yet hepcidindeficient and iron-loaded mouse strain suggested that the observed imbalances in tissue copper, zinc, and manganese levels were not all specific to hypotransferrinemic mice or caused directly by transferrin deficiency. Overall, our results suggest that transferrin does not have a primary role in the distribution of manganese, copper, or zinc to tissues and that the abnormalities observed in tissue manganese levels are not attributable to a direct role for transferrin in manganese metabolism but rather are attributable to an indirect effect of transferrin deficiency on hepcidin expression and/or iron metabolism.
Introduction
Our understanding of the role of the serum protein transferrin in mammalian iron metabolism is based partly on studies of a condition of inherited transferrin deficiency known as hypotransferrinemia [1] . Human cases of hypotransferrinemia are documented yet exceedingly rare. A murine model of hypotransferrinemia arose spontaneously in a BALB/cJ line several decades ago [2] . Hypotransferrinemic (hpx) mice are homozygous for a splicesite mutation in the transferrin gene that renders them transferrin-deficient [3, 4] . Hpx mice develop a profound anemia which necessitates treatment with exogenous transferrin prior to weaning to ensure their survival to adulthood. This anemia highlights the essential role of transferrin in iron delivery for erythropoiesis.
Transferrin is also an essential regulator of iron metabolism. This is best demonstrated by the iron overload that develops in transferrin-deficient patients and mice that do not receive transferrin treatment. Iron overload is most severe in the liver, but also has been documented in other organs, including the heart, kidneys, and pancreas [2, [4] [5] [6] . Iron overload stems from deficiency in hepcidin, a hormone secreted mainly by the liver that inhibits enterocyte and macrophage iron efflux. Hepcidin deficiency develops in the context of transferrin deficiency for two reasons [7] . First, transferrin directly stimulates hepcidin expression by the liver independently of transferrin's role in erythropoiesis. In conditions of transferrin deficiency, there is minimal transferrin-mediated stimulation of hepcidin expression. Second, transferrin is essential for delivery of iron to erythroid precursors. In the absence of transferrin-mediated erythroid iron delivery, the resulting anemia and/or hypoxia inhibit hepatic hepcidin expression, but the mechanism of inhibition is not well understood.
Although an essential role for transferrin in mammalian iron metabolism is firmly established, a role for transferrin in the distribution of other physiologic metals has not been thoroughly explored. Transferrin can bind a variety of physiologic and nonphysiologic metals in vitro, although the relevance of transferrin binding to physiologic metals other than iron is not well established in vivo [8] . Perhaps the most direct evidence of a role for transferrin in the distribution of other metals is the demonstration that 54 Mn cofractionates with transferrin in plasma harvested from rodents into which 54 Mn has been injected [9, 10] . To our knowledge, there are no in vivo data suggesting that transferrin binds or traffics copper or zinc. Therefore, we hypothesized that analysis of the serum and tissue distribution of iron, manganese, copper, and zinc in hpx mice would demonstrate severe imbalances for iron, possible imbalances for manganese, and no imbalances for copper or zinc relative to wild-type (wt) mice. If aberrant copper or zinc levels would be observed, they would occur after the onset of severe iron overload, possibly reflecting a secondary effect of severe iron overload on the tissue distribution of these metals. To test this hypothesis, we assessed metal content in transferrin-rich fractions of wt mouse sera and analogous fractions of hpx mouse sera. We also measured metal content in multiple tissues in wt and hpx mice of various ages. Here we present the results of these experiments and discuss possible implications of our findings.
Materials and methods
Animal studies were performed under a protocol approved by the Institutional Animal Care and Use Committee. Care and characterization of BALB/cJ hpx and C57BL/6J Tmprss6-deficient mice has been described [7, 11, 12] . Generation of hpx hemojuvelin (Hjv)-deficient mice from BALB/cJ hpx and C57BL6/J Hjv-deficient mice and their characterization has been described [12] . For harvest, mice were anesthetized and blood was collected by retro-orbital puncture. Mice were euthanized and tissues were immediately harvested and frozen in liquid nitrogen. Serum was isolated from blood using Microtainer serum separator tubes (Becton, Dickinson).
To fractionate serum, it was isolated from five to ten 2-to 4-month-old wt and hpx mice, pooled, and frozen at -80°C. Frozen serum was thawed, filtered, and diluted fivefold with 20 mM tris(hydroxymethyl)aminomethane (Tris) pH 8.0 wash buffer. Columns were washed with 10 column volumes (CV) of wash buffer. Five milliliters of diluted serum was applied at 1 mL/min to a GE HiTrap Blue column (5-mL CV), two Pierce protein A/G columns (1-mL CV each), and a GE HiTrap Q column (1-mL CV) in series. The columns were washed with 10 CV wash buffer. Bound proteins were eluted with 10 CV from the HiTrap Blue column with wash buffer/2 M NaCl, from the protein A/G columns with 0.1 M glycine pH 2.7 and from the HiTrap Q column with wash buffer/ 100 mM NaCl and wash buffer/1,000 mM NaCl. Flowthrough and eluates were collected, washed with wash buffer three times, and concentrated to 1 mL with Millipore 10-kDa molecular mass cutoff centrifugal filter units. Fractions were electrophoresed on NuPAGE 10 % [bis(2-hydroxyethyl)amino]tris(hydroxymethyl)methane gels (Life Technologies) and the gels were stained with SimplyBlue SafeStain (Life Technologies) or immunoblotted with transferrin-specific antibodies as described below.
To determine metal content by graphite furnace atomic absorption spectroscopy (GF-AAS) in serum fractions, 0.2 mL of each fraction was digested with 1 mL trace metal grade 70 % nitric acid at 65°C for 2 h, diluted 1:25 in trace metal grade water, and analyzed in triplicate using a PerkinElmer AAnalyst 600 atomic absorption spectrometer in the Environmental Chemistry Facility at Brown University. National Institutes of Standards and Technology certified reference material 1640a and chromatography buffers were also measured to ensure run consistency and assess background metal levels. Iron levels were also measured in undiluted serum using a bathophenanthrolinedisulfonate (BPS)-based assay [7] and a ferrozine-based iron/total iron-binding capacity reagent set (Pointe Scientific). To determine metal levels in unfractionated wt and hpx serum, 50 lL mouse serum was digested with 0.25 mL nitric acid, diluted 1:25 in water, then analyzed by GF-AAS.
To measure tissue metal levels, 50-200 mg of frozen tissues was thawed, weighed, and digested in 1 mL trace metal grade 70 % nitric acid at 65°C for 2 h, diluted 1:25 in trace metal grade water, and analyzed in triplicate using a JY2000 Ultrace inductively coupled plasma atomic emission spectrometer or by GF-AAS in the Environmental Chemistry Facility. Inductively coupled plasma atomic emission spectroscopy (ICP-AES) and GF-AAS were used to analyze concentrated and dilute samples, respectively. National Institutes of Standards and Technology certified reference material 1640a was also measured to ensure run consistency.
For gene expression and activity analysis, RNA was extracted from thawed tissues using Trizol and then subjected to DNase I treatment and reverse transcription using a high-capacity complementary DNA reverse transcription kit (Life Technologies). Gene expression was measured using TaqMan gene expression master mix and TaqMan gene expression assays Mm00444148 (Ccs), Mm01344233 (Sod1), Mm01313000 (Sod2), and Mm99999915 (Gapdh) (Life Technologies) with a ViiA 7 system (Applied Biosystems) using a relative standard curve approach. Proteins were extracted from thawed tissues by Dounce homogenization in 20 mM Tris pH 7.5/1 % Triton X-100/1 mM EDTA with protease inhibitors, centrifuged to pellet debris, then immunoblotted using NuPAGE 10 % [bis(2-hydroxyethyl)amino]tris(hydroxymethyl)methane gels (Life Technologies) and an ECL Western blotting analysis system (GE Life Sciences). The following antibodies (at the indicated dilutions) were used: rabbit anti-copper chaperone for superoxide dismutase (CCS) (1:1,000) [13] kindly provided by Joe Prohaska from the University of Minnesota (Duluth, MN, USA), Proteintech rabbit anti-copper/ zinc superoxide dismutase (SOD1) (1:1,000), Novus rabbit anti-manganese superoxide dismutase (SOD2) (1:1,000), Cell Signaling rabbit anti-glyceraldehyde 3-phosphate dehydrogenase (1:5,000), and Proteintech rabbit antitransferrin (1:500). Superoxide dismutase activity was analyzed using Novex Tris-glycine gels (Life Technologies) and a nitroblue tetrazolium based assay [14] . Bovine SOD1 was purchased from Sigma. SOD1-deficient mouse tissues were kindly provided by Rick Eisenstein from the University of Wisconsin-Madison (Madison, WI, USA). Densitometry was performed using ImageJ [15] .
Results
To explore a potential role for transferrin in the distribution of manganese, copper, and zinc, we first estimated the iron, manganese, copper, and zinc content of transferrin. We rationalized that the metal content in transferrin-rich fractions of wt mouse sera would represent the maximal amount of metal potentially bound to transferrin. Given that manganese cofractionates with transferrin in vivo, we predicted that both iron and manganese would cofractionate with transferrin, while copper and zinc would not. To isolate transferrin-rich fractions, we used a protocol that segregates transferrin into a low-salt anion-exchange fraction [1] . We analyzed pooled serum samples from wt and hpx mice given that our fractionation protocol behaved more consistently with larger starting volumes and serum volumes from individual mice were inadequate. Pooled serum samples were diluted and then applied to an albumin affinity column, an immunoglobulin affinity column, and an anion-exchange HiTrap Q column in series. Proteins were eluted from each column separately. Proteins were eluted from the HiTrap Q column with 100 mM NaCl (Q100 fraction) then 1,000 mM NaCl (Q1000 fraction). Eluates were washed and concentrated to the original serum volume by centrifugal filtration. Equal volumes of each fraction were analyzed by sodium dodecyl sulfatepolyacrylamide gel electrophoresis and Coomassie staining (Fig. 1a , left and center panels). A band in wt mouse sera but not hpx mouse sera and Q100 fractions migrated to a position consistent with transferrin's molecular mass of 75 kDa (Fig. 1a, asterisk) . Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Coomassie staining of a larger volume of specific fractions revealed the presence of multiple other bands of much lesser abundance in both wt mouse and hpx mouse Q100 fractions (Fig. 1a, right  panel) . Transferrin immunoblot detected a single band in wt mouse sera but not in hpx mouse sera or Q100 fractions migrating to a similar position as the Coomassie-stained band in the wt mouse Q100 fraction (Fig. 1b) . With our previous mass-spectrometric analysis identifying the most prominent band in low-salt Q fractions as transferrin [1] , our data indicated that the prominent band in the wt mouse Q100 fraction was transferrin.
GF-AAS was next used to measure the metal content in wt and hpx mouse sera, Q100 and Q1000 fractions, and in sera diluted and concentrated without any fractionation to assess the loss of metal during sample dilution and concentration (Figs. 1c, d , S1a, b). Iron levels were markedly increased in hpx mouse sera relative to wt mouse sera and were unaffected by dilution and concentration (Fig. 1c) . In wt and hpx mouse sera, most iron was contained in the Q100 and Q1000 fractions, respectively, suggesting a redistribution of iron to non-transferrin species in hpx mice. The increased iron levels in hpx mouse sera were striking, given that a commercial ferrene-based assay previously yielded decreased iron levels [7] . To address this, we measured iron levels in wt and hpx mouse sera using two other methods, a BPS-based assay and a commercial ferrozine-based assay-the ferrene-based assay was no longer available for purchase. Although the absolute iron levels in wt mouse sera were similar in all three assays, both GF-AAS and the BPSbased assay indicated increased iron levels in hpx sera, whereas the ferrozine-based assay, like the ferrene-based assay before, indicated decreased iron levels (data not shown). This discrepancy has been noted before in hpx mouse sera [16] , and suggests that not all iron assays measure non-transferrin-bound iron equivalently. To determine if this discrepancy was specific to hpx mouse sera, we measured serum iron levels in pooled sera from wt and Tmprss6-deficient mice. TMPRSS6 is a membrane-bound serine protease essential for downregulation of hepcidin expression [17] . Mice deficient in Tmprss6 develop hepcidin excess and systemic iron deficiency. Although the absolute iron levels in wt and Tmprss6-deficient mouse sera differed between assays, the levels were greater in wt mouse sera than in mutant mouse sera in all assays (data not shown), suggesting that the discrepancy noted above for hpx mouse sera is specific to non-transferrin-bound iron.
Manganese was most abundant in the wt mouse Q100 and hpx mouse Q1000 fractions (Fig. 1d) . Copper and zinc were below the level of detection or were present at low levels in Q100 fractions but were abundant in Q1000 fractions (Fig. S1a, b) . Hpx mouse sera manganese levels and wt mouse sera zinc levels decreased with dilution and concentration (serum* in Figs. 1d, S1b), suggesting that some serum manganese and zinc were associated with low molecular weight species, as 10-kDa cutoff centrifugal filter units were used to concentrate samples. Overall, our data are consistent with transferrin as the main iron-binding and manganese-binding, but not copper-binding or zincbinding, protein in the serum. However, the absolute manganese levels in unfractionated sera and Q100 fractions were two orders of magnitude below the iron levels. If transferrin is the main serum manganese-binding protein, iron-replete transferrin is much more abundant than manganese-replete transferrin.
We pooled sera from several mice because our fractionation protocol behaved more consistently with larger Wild-type (wt) and hypotransferrinemic (hpx) mouse sera were pooled from five to ten 2-to 4-month-old mice. Sera were applied to albumin affinity (HiTrap Blue), immunoglobulin affinity (protein A/ G) and anion-exchange (HiTrap Q) columns in series and were then eluted from individual columns. Proteins were eluted from the HiTrap Q column with 100 mM NaCl (Q100) then 1,000 mM NaCl (Q1000). Column flowthrough (FT) and all eluates were washed and concentrated to the original serum volume. a Fractions (left and center panels) and larger volumes of select fractions (right panel)
were electrophoresed under denaturing, reducing conditions on polyacrylamide gels and then stained to visualize proteins. An asterisk indicates the transferrin band. b Fractions were immunoblotted with a transferrin-specific antibody. The upper image and the lower image correspond to short and long exposures, respectively. Iron (c) and manganese (d) levels in wt and hpx mouse sera and fractions were measured by graphite furnace atomic absorption spectrometry (GF-AAS) in triplicate. Serum* indicates sera diluted then concentrated without fractionation, and n.d. indicates the value was below the lower limit of detection. Tf transferrin starting volumes; however, this did not permit us to examine metal content in sera of individual mice. To address this, we analyzed metal content individually in smaller volumes of serum from wt and hpx mice by GF-AAS (Fig. S1c) . Serum iron and zinc levels were decreased in hpx mice relative to wt mice. Serum copper and manganese levels did not differ between genotypes. The observation that serum iron levels were decreased in hpx mice in Fig. S1c contrasts with our observation that iron levels were increased in pooled hpx mouse sera in Fig. 1c . The serum iron levels in Figs. S1c and 1c, respectively, represent 1-month-old and 2-to 4-month-old mice. Hpx mice receive weekly intraperitoneal transferrin injections prior to weaning to ensure their survival to weaning age. Although all hpx mice were anemic at the 1-month time of harvest (data not shown) and iron loading worsens progressively in hpx mice (see below), the difference in hpx serum iron levels in Figs. S1c and 1c most likely reflects the fact that non-transferrin-bound iron levels had not yet started to increase at 1 month of age. We presume that with age and continued hepcidin deficiency in hpx mice, excessive dietary iron absorption eventually increases nontransferrin-bound iron levels to levels above those in wt mice.
The above results suggested that transferrin binds iron predominantly. However, hpx mice could still display a defect in the distribution of manganese, copper, and zinc if transferrin deficiency has an indirect effect on those metals. To examine this, we measured wt and hpx mouse tissue metal levels by ICP-AES and GF-AAS, with the former and latter used for more concentrated and diluted samples, respectively. Iron levels increased with age in liver, spleen, kidney, lung, heart, and pancreas of hpx mice, and were greater at all ages in hpx mice than in wt mice for all tissues except spleen (Fig. 2) . Manganese levels were increased significantly or near significantly at all ages in hpx mouse liver and lung relative to wt mouse liver and lung (Fig. 3) . Copper levels decreased in hpx mouse liver with age and were decreased relative to the levels in wt mouse liver at 120 days (Fig. S2) . Copper levels were greater in hpx mouse spleen and lung than in wt mouse spleen and lung at all ages (Fig. S2) . Similarly to copper, zinc levels decreased in hpx mouse liver with age and were decreased relative to the levels in wt mouse liver at 60 and 120 days (Fig. S3) . Decreased zinc levels were noted at 120 days in hpx mouse heart and pancreas relative to wt mouse heart and pancreas (Fig. S3) . We also measured metal levels in quadriceps muscle and femur from 4-month-old wt and hpx mice. Although iron levels were significantly elevated in hpx mouse muscle and bone, there were no differences in manganese, copper, or zinc levels in these tissues between wt and hpx mice (Figs. 4, S4) . Overall, hpx mouse tissue metal imbalances were most prominent for iron, and much less prominent defects were noted for copper, zinc, and manganese in some tissues at some ages. To determine if the observed tissue metal imbalances were unique to hpx mice, we analyzed livers from mice deficient in Hjv. Hjv is a bone morphogenetic coreceptor essential for hepcidin expression. Like hpx mice, Hjvdeficient mice develop hepcidin deficiency and iron overload. Unlike hpx mice, Hjv-deficient mice do not have transferrin deficiency. We took advantage of previous work in which we generated mice deficient in both transferrin and Hjv and analyzed samples from these mice to demonstrate that Hjv is essential for transferrin-dependent hepcidin expression [12] . Measurement of liver metal levels by ICP-AES demonstrated increased iron levels in hpx, Hjv-deficient, and hpx Hjv-deficient mice, as previously demonstrated by BPS-based iron assay (Fig. 5a ). Manganese levels were also increased in hpx mice and Hjv-deficient mice relative to wt mice and in hpx Hjvdeficient mice relative to Hjv-deficient mice (Fig. 5b) . No significant changes in copper or zinc levels were detected in these mice (Fig. S5) . These data suggested that the increased manganese levels observed in hpx mouse liver do not directly reflect transferrin deficiency but are rather a consequence of transferrin deficiency such as hepcidin deficiency or iron overload.
To explore the hpx mouse tissue metal imbalances further, we interrogated the CCS-SOD1 pathway, a relatively well characterized pathway of mammalian metal biology. CCS is essential for incorporation of copper into the antioxidant protein SOD1 [18] . Mice with copper deficiency induced by dietary restriction possess increased CCS levels, decreased SOD1 levels, but unchanged Ccs and Sod1 RNA levels [13, 19] . We measured hepatic expression of Ccs, Sod1, and Sod2 by quantitative PCR, immunoblots, and activity gels. The specificity of SOD1 activity bands was demonstrated by analysis of wt and SOD1-deficient Fig. 3 Tissue manganese levels in hpx mice. Manganese levels in liver (a), spleen (b), kidney (c), lung (d), heart (e), and pancreas (f) were measured and plotted as described in the caption for Fig. 2 mouse lysates; superoxide dismutase activity gel linearity was demonstrated by analysis of increasing amounts of purified bovine SOD1 (Fig. S6a, b) . Ccs and Sod1 RNA levels were decreased in hpx mouse livers relative to wt mouse livers by 120 days of age (Fig. S6c) . CCS and SOD2 levels were unchanged, but SOD1 levels were decreased in hpx mouse livers relative to wt mouse livers at 30 and 120 days of age (Fig. S6d, e) . SOD1 activity levels were decreased in hpx mouse livers relative to wt mouse livers only at 120 days of age (Fig. S5d, e) .
The cause of decreased SOD1 protein levels in 30-and 120-day-old hpx mouse liver and decreased SOD1 activity only in 120-day-old hpx mouse liver is unclear. Notably, SOD1 activity levels were unchanged and SOD1 protein levels were decreased in 30-day-old hpx mice relative to wt mice, suggesting that SOD1 was more active in hpx mice than in wt mice at this age. The percent decrease in SOD1 activity was less than the percent decrease in the protein levels in 120-day-old hpx mouse liver relative to wt mouse liver, also suggesting that SOD1 was more active in hpx and wt mice at this age. We speculate that hpx mouse iron overload impacts steady-state SOD1 protein and activity levels, although there is no literature precedent to currently support this. Overall, other than the finding of decreased SOD1 activity at 30 days of age, all noted defects in the CCS-SOD1 pathway had a later age of onset than iron overload in hpx mice.
Discussion
Perhaps the most direct experimental data supporting an in vivo link between transferrin and an essential metal other than iron are the demonstrations that transferrin is the main manganese-binding protein in the circulation [8] . Biochemical fractionation of plasma harvested from rodents into which 54 Mn had been injected intraperitoneally or intravenously indicates that manganese cofractionates with transferrin [9, 10] . Although hpx mice are a potentially productive model for studies of the role of transferrin in the distribution of metals other than iron, studies in these mice have focused predominantly on the tissue uptake and distribution of injected 54 Mn. One study demonstrated that transferrin is required for distribution of intravenously injected 54 Mn within but not to the brain [20] . Another study showed that transferrin is not required for distribution of subcutaneously injected 54 Mn to brain, heart, and bone, although increased 54 Mn uptake was observed in liver soon after injection [21] . To our knowledge, no study has yet to examine the relative abundance of iron versus manganese, copper, and zinc in transferrin-rich serum or plasma fractions or the absolute tissue levels of manganese, copper, or zinc in hpx mice, as we have performed. Our data recapitulate the above-mentioned findings that manganese fractionates predominantly with transferrin. However, given our observed concentrations of manganese and iron in transferrin-rich serum fractions, manganese-replete transferrin is much less abundant than iron-replete transferrin, assuming that manganese present in transferrin-rich fractions represents transferrin-bound manganese. This finding, together with the lack of prominent imbalances in tissue manganese levels in hpx mice, implies that transferrin is not essential for distribution of manganese to various tissues under conditions present in hpx mice. However, these data do not exclude the possibility that transferrin is essential for manganese distribution under conditions of manganese deficiency or overload or distribution of manganese, copper, or zinc within tissues.
Although hpx mice do exhibit some mild alterations in the tissue content of manganese, copper, and zinc, our analyses suggest that these alterations may not be specific to hpx mice and/or may reflect the secondary effects of severe iron overload or other consequences of transferrin deficiency-the observed increases in liver manganese levels in hpx mice and hpx Hjv-deficient mice relative to wt mice may simply reflect a redistribution of manganese from serum to liver. There is literature supporting a link between iron overload and perturbations in the levels of other metals. Aberrant intestinal manganese absorption and intracellular manganese distribution have been demonstrated in a mouse model of hemochromatosis, an inherited disease of iron overload due to mutations in genes required for hepcidin expression [22, 23] . Increased hepatic zinc content was observed after iron loading of mice by intraperitoneal iron dextran injections [24] . Mild copper deficiency in the heart and liver developed in rats fed a high-iron diet [25] . Increased manganese and zinc content in the liver and spleen was noted after iron loading of rats by diet or injection [26] . Whether these findings reflect shared physiologic pathways underlying iron and manganese transport or solely reflect the pathophysiologic effect of iron overload on other metals remains to be determined.
In this article, we initially predicted that hpx mice would not display aberrant levels of copper or zinc but may display aberrant levels of tissue manganese. Although our data do not suggest an essential role for transferrin in the distribution of manganese in hpx mice, several other overlaps between iron and manganese transport have already been established or suggested. Divalent metal transporter 1 (DMT1) was first characterized in vivo in studies of microcytic mice and Belgrade rats, two rodent models that harbor missense Dmt1 mutations [27] . These animal models exhibit a microcytic anemia indicative of DMT1's role in intestinal iron absorption and erythroid iron uptake. These animals also display similar defects in manganese transport, indicating that manganese and iron share some similar transport mechanisms. Less well explored than the role of DMT1 in manganese metabolism is the putative role of the cellular iron exporter ferroportin. A membrane protein expressed largely in enterocytes and macrophages, ferroportin is internalized and degraded after binding by hepcidin [17] . Hepcidin-dependent regulation of ferroportin serves as the mechanism by which hepcidin limits dietary iron absorption and macrophage iron release. In vitro studies have suggested that ferroportin mediates cellular manganese efflux [28, 29] . Increased 54 Mn absorption occurs after intragastric administration of 54 Mn in a mouse model of hemochromatosis, a disease of primary hepcidin deficiency, although a role for ferroportin or DMT1 in this process was not formally demonstrated [22] .
One key difference between iron and manganese metabolism is the means of elimination of each metal from the body. Unlike iron, manganese undergoes hepatobiliary excretion under homeostatic conditions. Although the molecular mechanism of hepatobiliary manganese excretion has yet to be established, mutations in SLC30A10, a putative metal transporter expressed in liver and brain, were recently identified in patients with inherited manganese excess, Parkinson-like neurologic defects, and liver dysfunction [30] [31] [32] . If SLC30A10 does mediate the transport of manganese out of hepatocytes into bile, it is unlikely that it also transports iron, given that iron does not undergo hepatobiliary excretion under homeostatic conditions. This suggests that although iron and manganese share some transport pathways, they do not share all transport pathways.
